Local Use of Ankaferd Blood Clotter in Emergent Beating Heart Coronary Artery Bypass Grafting

Hakan Atalay1, Atakan Atalay2, Omer F. Dogan3, *
1 Department of Cardiovascular Surgery, Mersin Private Middle-East Hospital, Mersin
2 Department of Cardiovascular Surgery, Cukurova University Medical Faculty, Adana, Turkey
3 Department of Cardiovascular Surgery, Adana Numune Education and Training Hospital, Adana, Turkey

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 2270
Abstract HTML Views: 618
PDF Downloads: 428
Total Views/Downloads: 3316
Unique Statistics:

Full-Text HTML Views: 894
Abstract HTML Views: 364
PDF Downloads: 269
Total Views/Downloads: 1527

Creative Commons License
© Dogan et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Seyhan Education and Training Hospital, Suleyman Demirel Bulvarı, 01600, Çukurova, Adana, TURKEY; Tel: +90 533 4813056; Fax: +90 322 2143615;, E-mail:



Severe beeding which requiring massive blood transfusion after emergent beating heart surgery is shown to be 1–3%. Therefore, complications and side effects of transfusion can be seen. The aim of this study was to investigate the effectiveness of Ankaferd blood clotter (ABC) as a new topical herbal blood clotter to decrease mediastinal bleeding in emergent beating heart CABG patients who medicated with clopidogrel and acetyl salisilic acite (ASA) prior to CABG surgery.

Materials and Methods:

25 CABG patients received a high dose clopidogrel (600 mgr) and 300 mgr ASA have been included into the study (ABC group). 25 patients have also been included into the study for comparison (placebo group, PG). After the administration of protamine sulphate, a 10 ml of ABC solution has been sprayed to the surgical area including mediastinum and epicardial sac. We compared mediastinal drenaige, reoperation due to tamponade, and required blood and blood products in both groups.


The mean amount of bleeding after operation was 230 ml in ABC group, and 490 ml in CG (P=0.001). In ICU, bleeding in ABC group and CG was 410ml and 680ml, respectively (P=0.0022). The mean total bleeding from mediastinum was 530±280 mL and 990±440 mL In ABC and CG group, respectively (P=0.001). The amount of autotransfusion was as follows: 175 mL in ABC group, and 290 mL in CG (P=0.002). No patient needed the surgical revision in ABC group, but four patients (16%) from CG group because of cardiac tamponade. Seventeen patients from CG required blood transfusion due to low hematocrite level postoperatively. In CG, the mean hematocrite level was 17±2,3. Transfusion of fresh frozen plasma and platelets in ABC group and CG were as follows: 0.2 and 0 in ABC group, and 0.3and 0.4 in CG.


Our study showed that the local use of 10 mL ABC reduces bleeding significantly. Therefore, transfusion requirements of PRBC, platelets, and total blood units in patients on clopidogrel and ASA undergoing emergent beating heart CABG. To provide cardiac tamponade because of excessive mediastinal bleeding and requirement of blood transfusion after emergent CABG patients who previously administered clopidogrel and ASA, we propose local use of ABC solution as a potent coagulant agent.

Keywords: : Ankaferd blood clotter, haemostasis, beating heart CABG.